Review by Joe Maroon, MD

I recently reviewed the work of Quorum Innovations and its physician-scientist founders, Nicholas Monsul and Eva Berkes, and could not be more impressed by the originality and scientific sophistication of their platform. Leveraging years of DARPA-supported microbiome and biofilm research, they have developed what may represent the first orally administered technology designed to physically bind microplastics during ingestion and help prevent their absorption into the body, a potentially groundbreaking advancement in preventative medicine and environmental health. Their work sits at the intersection of microbiome science, neuroscience, barrier protection, and public health, and I believe it represents one of the most innovative translational biomedical efforts I have encountered in years.  A huge congratulations on publishing the first study demonstrating, in human testing, that Qi601 can bind microplastic particles in people.

Joe Maroon, MD

Neurosurgeon , Author and Ironman Triathlete

Internationally recognized Neurosurgeon

Specialist in Healthy  Aging and Longevity